| Schedule of Computation of Basic and Diluted EPS |
The following table sets forth the computation of basic and diluted EPS. Prior to the IPO, Legence Holdings was a single-member limited liability company and did not present earnings per share. Due to the IPO and Corporate Reorganization, the Company’s capital structure before and after the IPO is not comparable and would not be meaningful to the users of these Condensed Consolidated financial statements. As a result, only earnings per share for the three and six months ended June 30, 2026 are presented. | | | | | | | | | | | | | (in thousands, except per share data) | Three Months Ended June 30, 2026 | | Six Months Ended June 30, 2026 | | Numerator—basic: | | | | | Net loss | $ | (34,564) | | | $ | (17,170) | | | Less: Net loss attributable to noncontrolling interests | (6,723) | | (5,423) | | Net loss attributable to Legence—basic | $ | (27,841) | | | $ | (11,747) | | | Denominator—basic: | | | | | Weighted-average Class A Common Stock outstanding—basic | 76,032 | | 71,616 | | Loss per share—basic | $ | (0.37) | | | $ | (0.16) | | | | | | | Numerator—diluted: | | | | | Net loss attributable to Class A Common Stockholders—basic | $ | (27,841) | | | $ | (11,747) | | | Effect of assumed exchange of LGN B Units | — | | | (10,873) | | | Effect of exchange of LGN B Units related to exercise of underwriters' overallotment option and Subsequent Secondary Offering | — | | | (1,810) | | | Net loss attributable to Class A Common Stockholders—diluted | $ | (27,841) | | | $ | (24,430) | | | Denominator—diluted: | | | | | Weighted-average Class A Common Stock outstanding—basic | 76,032 | | | 71,616 | | | Weighted-average effect of dilutive securities: | | | | | Effect of assumed exchange of LGN B Units | — | | | 31,171 | | | Effect of exchange of LGN B Units related to exercise of underwriters' overallotment option and Subsequent Secondary Offering | — | | | 5,189 | | | Weighted-average Class A Common Stock outstanding—diluted | 76,032 | | | 107,976 | | | Loss per share—diluted | $ | (0.37) | | | $ | (0.23) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Anti-dilutive securities that could potentially dilute EPS in the future are set forth below (in thousands): | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | Six Months Ended June 30, 2026 | | Stock options | 845 | | | 845 | | | RSUs | 1,417 | | | 1,417 | | | LGN B Units exchangeable for Class A Common Stock | 31,171 | | | — | | | Deferred consideration related to Bowers acquisition | 612 | | | 612 | |
|